CRISPR by Design™
Scribe is enabling the creation of genetic medicines through its CRISPR by Design™ approach to genetic modification.
There is no investment information
No recent news or press coverage available for Scribe Therapeutics.
We care about your data, and we'd love to use cookies make your experience better.